See what a stock claim requires before you rely on it.
These are curated snapshots from real TickerCase analyses—not generic templates. Each case freezes the claim and reference date, shows what the public record supports, and defines what would have to happen next.
Research scenarios only. A verdict describes support for the exact claim on the analysis date; it is not a buy or sell rating.
Can NVTS rise 500%? The hyperscaler claim still needs a contract.
“Navitas is expected to win at least one major hyperscaler customer within 12 months—a key condition behind a 500%+ upside thesis.”
TickerCase extracted a testable prediction from a YouTube transcript, then separated management’s AI-program commentary from evidence of a funded customer award.
Newer filings, results, or prices may change this result.
Claim math$11.80 → $70.80+500% by September 5, 2027
Indicative market value$3.08B → $18.49BUsing the report’s validated share base
Constant-multiple revenue test$36.53M → $219.21MAbout 6× revenue; scenario, not forecast
Three Claim Archetypes
Different claims fail in different ways.
NBISPercentage-return target
Analyzed · Dated snapshot
Can NBIS double in 12 months? Growth is real; the valuation bridge is not proven.
“NBIS will double in 12 months.”
NBIS would need to rise from $226.39 to $452.78 by September 5, 2027. AI-cloud revenue and segment EBITDA surged, but a doubling still requires durable cash conversion and valuation support despite major debt and dilution exposure.
Newer filings, results, or prices may change this result.
What would RKLB need to reach $200? The missing deadline matters.
“RKLB will reach $200.”
From $64.26, RKLB needs a 211.2% gain to reach $200. The report used September 5, 2031 as an estimated research deadline—not a speaker-supplied promise. Record backlog and revenue momentum help, but profitable Neutron execution, controlled dilution, and premium valuation support remain necessary.
Newer filings, results, or prices may change this result.
Will a congressional trade make BE rise? The company still has to deliver.
“BE will rise over the next 12 months because a disclosed congressional trade shows conviction in the stock.”
The literal price test is whether BE finishes above $252.87 on September 5, 2027. Bloom’s Q2 growth, operating income, cash flow, and raised guidance support business momentum; a reported political transaction does not by itself demonstrate predictive edge or define how much upside to expect.
Newer filings, results, or prices may change this result.
Literal directional test>$252.87At the September 5, 2027 deadline